Sun Pharma plants get US regulatory clearance
By Our Corporate Bureau | 28 May 2004
Mumbai:
Two
of Sun Pharma''s factories have received clearance from
the US regulatory authorities for manufacturing for the
US market. The company''s bulk actives plant at Panoli,
that manufactures the ingredients that go into medicines
and tablet-making plant at Halol were inspected and cleared
by the US-Food and Drug Administration , the company said
in a statement released yesterday.
With the recent approvals, Sun Pharma now has a total of three factories that are ready to manufacture for the US, including its Ahmednagar site.
For Sun''s Panoli factory, the USFDA approval is the second international clearance, the first being from the European regulatory authorities. Europe-based innovator companies have been sourcing from this plant, the release said.